Lanzol

Lansoprazole, the active ingredient in Lanzol, is a proton pump inhibitor presented as a tablet for oral use. It reduces gastric acid production and is used to treat conditions such as gastro‑oesophageal reflux disease, peptic ulcers and related disorders in adults.

GNH USA supplies Lanzol as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Lansoprazole is a proton pump inhibitor used to manage acid‑related gastrointestinal conditions.

- Gastro‑oesophageal reflux disease (GERD): provides symptomatic relief and promotes healing of esophageal irritation. - Erosive esophagitis: heals erosive lesions and reduces recurrence risk. - Peptic ulcer disease: accelerates ulcer healing and lowers the chance of recurrence. - Helicobacter pylori eradication regimens: used as part of combination therapy to improve eradication rates. - Zollinger‑Ellison syndrome: controls excessive gastric acid secretion.

Lansoprazole may cause a range of adverse reactions, most of which are mild and reversible.

Common Side Effects: - Headache: mild to moderate intensity. - Diarrhea: usually self‑limiting. - Nausea: occasional, may improve with food. - Abdominal pain: mild discomfort. - Flatulence: increased gas. - Constipation: infrequent.

Serious or Rare Side Effects: - Severe allergic reaction (anaphylaxis): requires immediate medical attention. - Clostridioides difficile infection: can cause severe colitis. - Low magnesium levels (hypomagnesemia): may lead to muscle cramps or arrhythmias. - Interstitial nephritis: rare kidney inflammation.

When prescribing Lanzol, clinicians should consider several safety and handling points.

- Assess renal function: adjust use in severe renal impairment. - Monitor for infection: prolonged therapy may increase risk of gastrointestinal infections. - Check magnesium levels: long‑term use can lead to hypomagnesemia. - Avoid abrupt discontinuation: may cause rebound acid hypersecretion. - Pregnancy and lactation: use only if benefit outweighs risk, as safety data are limited. - Store at ambient temperature: keep below 25 °C, in original packaging, protected from moisture.

Lansoprazole can affect the plasma concentrations of several co‑administered medicines.

Major Interactions (Avoid): - Ketoconazole: reduced absorption, avoid co‑administration. - Atazanavir: markedly decreased exposure, avoid. - Clopidogrel: reduced activation, avoid.

Moderate Interactions (Monitor Closely): - Warfarin: may increase INR, monitor coagulation. - Methotrexate: increased serum levels, monitor toxicity. - Digoxin: may increase levels, monitor cardiac function.